Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10Â years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy

Trial registration: EudraCT Number: 2013-001602-28; clinicaltrials.gov: NCT02012998